Back
Hisamitsu Pharmaceutical Quote, Financials, Valuation and Earnings
Sponsored
HTSUF
Sponsored
The dark truth about AI
Click here to learn more...
Buy
52
HTSUF
Hisamitsu Pharmaceutical
Last Price:
24.56
Seasonality Move:
3.79%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)Hisamitsu Pharmaceutical Price Quote
$24.56
Hisamitsu Pharmaceutical Key Stats
Buy
52
Hisamitsu Pharmaceutical (HTSUF)
is a Buy
Day range:
$24.56 - $24.56
52-week range:
$23.70 - $34.00
Dividend yield:
2.36%
P/E ratio:
19.35
P/S ratio:
1.85
P/B ratio:
0.96%
Volume:
0
Avg. volume:
0
1-year change:
-27.77%
Market cap:
$1.8B
Revenue:
$991.5M
EPS:
$1.29
How Much Does Hisamitsu Pharmaceutical Make?
-
How Much Are Hisamitsu Pharmaceutical's Sales Annually?
HTSUF Revenues are $991.5M -
How Much Profit Does Hisamitsu Pharmaceutical's Make A Year?
HTSUF net income is $97.7M
Is Hisamitsu Pharmaceutical Growing As A Company?
-
What Is Hisamitsu Pharmaceutical's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.05% -
What Is Hisamitsu Pharmaceutical's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.03%
Hisamitsu Pharmaceutical Stock Price Performance
-
Did Hisamitsu Pharmaceutical Stock Go Up Last Month?
Hisamitsu Pharmaceutical share price went up by 0% last month -
Did HTSUF's Share Price Rise Over The Last Year?
HTSUF share price fell by -27.77% over the past 1 year
What Is Hisamitsu Pharmaceutical 52-Week High & Low?
-
What Is Hisamitsu Pharmaceutical’s 52-Week High Share Price?
Hisamitsu Pharmaceutical has traded as high as $34.00 over the past 52 weeks -
What Is Hisamitsu Pharmaceutical’s 52-Week Low Share Price?
Hisamitsu Pharmaceutical has traded as low as $23.70 over the past 52 weeks
Hisamitsu Pharmaceutical Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Hisamitsu Pharmaceutical?
-
How Much Debt Does Hisamitsu Pharmaceutical Have?
Total long term debt quarterly is $7.6M -
How Much Cash Does Hisamitsu Pharmaceutical Have?
Cash and short term investments quarterly total is $839.4M -
What Is Hisamitsu Pharmaceutical’s Book Value Per Share?
Book value per share is 25.51
Is Hisamitsu Pharmaceutical Cash Flow Positive?
Data Unavailable
Hisamitsu Pharmaceutical Return On Invested Capital
-
Is Management Doing A Good Job?
HTSUF return on invested capital is 5.3% -
What Is Hisamitsu Pharmaceutical Return On Assets?
ROA measures how assets are converting to revenues and is 4.26% -
What Is HTSUF Return On Equity?
ROE is a measure of profitability and is 5.33%
Hisamitsu Pharmaceutical Earnings Date & Stock Price
-
What Is Hisamitsu Pharmaceutical's Stock Price Today?
A single share of HTSUF can be purchased today for 24.56 -
What Is Hisamitsu Pharmaceutical’s Stock Symbol?
Hisamitsu Pharmaceutical trades on the otcm under the ticker symbol: HTSUF -
When Is Hisamitsu Pharmaceutical’s Next Earnings Date?
The next quarterly earnings date for Hisamitsu Pharmaceutical is scheduled on December 15, 2024 -
When Is HTSUF's next ex-dividend date?
Hisamitsu Pharmaceutical's next ex-dividend date is February 27, 2025 -
How To Buy Hisamitsu Pharmaceutical Stock?
You can buy Hisamitsu Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Hisamitsu Pharmaceutical Competitors
-
Who Are Hisamitsu Pharmaceutical's Competitors?
Below is a list of companies who compete with Hisamitsu Pharmaceutical or are related in some way:
Hisamitsu Pharmaceutical Dividend Yield
-
What Is HTSUF Dividend Yield?
Hisamitsu Pharmaceutical’s dividend yield currently is 2.36% -
What Is Hisamitsu Pharmaceutical’s Payout Ratio?
Hisamitsu Pharmaceutical’s payout ratio is 0% -
When Did Hisamitsu Pharmaceutical Last Pay A Dividend?
The latest dividend pay date is December 15, 2024 -
What Is Hisamitsu Pharmaceutical’s Dividend Per Share?
Hisamitsu Pharmaceutical pays a dividend of $0.28 per share
Hisamitsu Pharmaceutical Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -3.11% | 0% |
Revenue: | 5.35% | 0% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 0.00 |
Downside from Last Price: | -100% |